Clinical Trial
doi: 10.1097/00004583-200212000-00010.Lofexidine in hyperactive and impulsive children with autistic disorder
- PMID:12447025
- DOI: 10.1097/00004583-200212000-00010
Item in Clipboard
Clinical Trial
Lofexidine in hyperactive and impulsive children with autistic disorder
Helmut Niederhofer et al. J Am Acad Child Adolesc Psychiatry.2002 Dec.
Display options
Format
Display options
Format
No abstract available
Similar articles
- Clonidine treatment of hyperactive and impulsive children with autistic disorder.Jaselskis CA, Cook EH Jr, Fletcher KE, Leventhal BL.Jaselskis CA, et al.J Clin Psychopharmacol. 1992 Oct;12(5):322-7.J Clin Psychopharmacol. 1992.PMID:1479049Clinical Trial.
- Use of clonidine in children with autism spectrum disorders.Ming X, Gordon E, Kang N, Wagner GC.Ming X, et al.Brain Dev. 2008 Aug;30(7):454-60. doi: 10.1016/j.braindev.2007.12.007. Epub 2008 Feb 15.Brain Dev. 2008.PMID:18280681Clinical Trial.
- The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.Willemsen-Swinkels SH, Buitelaar JK, van Engeland H.Willemsen-Swinkels SH, et al.Biol Psychiatry. 1996 Jun 15;39(12):1023-31. doi: 10.1016/0006-3223(95)00297-9.Biol Psychiatry. 1996.PMID:8780837Clinical Trial.
- Pharmacotherapy of irritability in pervasive developmental disorders.Stigler KA, McDougle CJ.Stigler KA, et al.Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002.Child Adolesc Psychiatr Clin N Am. 2008.PMID:18775367Review.
- Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.Aman MG, Farmer CA, Hollway J, Arnold LE.Aman MG, et al.Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):713-38, vii. doi: 10.1016/j.chc.2008.06.009.Child Adolesc Psychiatr Clin N Am. 2008.PMID:18775366Free PMC article.Review.
Cited by
- What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?Ewing GE.Ewing GE.N Am J Med Sci. 2009 Jul;1(2):28-47.N Am J Med Sci. 2009.PMID:22666668Free PMC article.
- Efficacy and Safety of Alpha-2 Agonists in Autism Spectrum Disorder: A Systematic Review.Kaye AD, Green AM, Claude JT 2nd, Daniel CP, Cooley JF, Sala KR, Potharaju P, Rieger R, Patil S, Ahmadzadeh S, Shekoohi S.Kaye AD, et al.Adv Ther. 2024 Nov;41(11):4299-4311. doi: 10.1007/s12325-024-02980-0. Epub 2024 Sep 13.Adv Ther. 2024.PMID:39269569Review.
- Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.Howes OD, Rogdaki M, Findon JL, Wichers RH, Charman T, King BH, Loth E, McAlonan GM, McCracken JT, Parr JR, Povey C, Santosh P, Wallace S, Simonoff E, Murphy DG.Howes OD, et al.J Psychopharmacol. 2018 Jan;32(1):3-29. doi: 10.1177/0269881117741766. Epub 2017 Dec 14.J Psychopharmacol. 2018.PMID:29237331Free PMC article.Review.
- Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).Iffland M, Livingstone N, Jorgensen M, Hazell P, Gillies D.Iffland M, et al.Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2.Cochrane Database Syst Rev. 2023.PMID:37811711Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources